Comparison of efficacy of Varenicline and transcranial direct current stimulation (tDCS) in smoke cessatio

Phase 4

Recruiting

• Conditions: icotine dependence.; Nicotine dependence, cigarettes; F17.21

• Registration Number: IRCT20181026041468N4
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

Smokers at the age of 18-65
Having a minimum literacy
Informed consent

Exclusion Criteria

Request from the patient or the patient's legal guardian to leave the study at any time of the study
Occurrence of harmful or intrusive side effects due to Varenicline or tDCS
Any contraindications of tDCS
Epilepsy
Dementia, delirium or other cognitive disorders
Any history of psychiatric disorders
Severe smoking
Any history of attempting to smoke cessation including, Varenicline or Bupropion tablets, Nicotine gum and nicotine patch

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Smoke cessation. Timepoint: Beginning and the end of the intervention. Method of measurement: Nicotine dependence scale (NDSS).